Revolution Medicines, Inc. (RVMD) quarterly income statement — complete revenue, gross profit & net income history
Revolution Medicines, Inc. (RVMD) annual income statement — 9-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 197.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 742K | 0 | 3.82M | 7.01M | 15.33M | 3.36M | 9.12M | 7.58M | 9.46M |
| Revenue Growth % | - | - | - | - | - | - | - | -100% | - | -100% | -100% | -95.16% | -100% | -58.05% | -7.44% | 62.05% | 204.81% | 4.81% | -25.2% | 8.1% |
| Cost of Goods Sold | 327K | 0 | 4.54M | 4.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 0.17% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 197.23M | 0 | -4.54M | -4.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 742K | 0 | 3.82M | 7.01M | 15.33M | 3.36M | 9.12M | 7.58M | 9.46M |
| Gross Margin % | 99.83% | - | - | - | - | - | - | - | - | - | - | 100% | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | - | - | - | - | - | - | -100% | - | -100% | -100% | -95.16% | -100% | -58.05% | -7.44% | 62.05% | 204.81% | 4.81% | -25.2% | 8.1% |
| Operating Expenses | 570.38M | 505.13M | 440.69M | 356.92M | 315.27M | 264.71M | 240.76M | 216.31M | 175.71M | 156.64M | 140.86M | 180.72M | 123.25M | 112.62M | 82.17M | 77.04M | 79.89M | 71.2M | 65.53M | 62.37M |
| OpEx % of Revenue | 288.71% | - | - | - | - | - | - | - | - | - | - | 24356.47% | - | 2945.11% | 1171.53% | 502.52% | 2380.48% | 781.1% | 864.7% | 659.33% |
| Selling, General & Admin | 153.29M | 110.21M | 101.25M | 64.32M | 52.76M | 40.58M | 35.01M | 28.21M | 23.96M | 21.71M | 22.84M | 32.24M | 15.51M | 14.64M | 13.22M | 10.91M | 10.43M | 10.2M | 9.04M | 8.69M |
| SG&A % of Revenue | 77.59% | - | - | - | - | - | - | - | - | - | - | 4345.55% | - | 382.85% | 188.54% | 71.17% | 310.91% | 111.94% | 119.25% | 91.88% |
| Research & Development | 417.09M | 394.92M | 343.97M | 292.61M | 262.51M | 224.13M | 205.75M | 188.1M | 151.75M | 134.93M | 118.02M | 148.48M | 107.73M | 97.98M | 68.95M | 66.13M | 69.45M | 61M | 56.49M | 53.68M |
| R&D % of Revenue | 211.12% | - | - | - | - | - | - | - | - | - | - | 20010.92% | - | 2562.26% | 982.99% | 431.36% | 2069.58% | 669.16% | 745.45% | 567.45% |
| Other Operating Expenses | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -373.15M | -505.13M | -445.22M | -361.63M | -315.27M | -264.71M | -240.76M | -216.31M | -175.71M | -156.64M | -140.86M | -179.98M | -123.25M | -108.8M | -75.16M | -61.71M | -76.53M | -62.09M | -57.95M | -52.91M |
| Operating Margin % | -188.88% | - | - | - | - | - | - | - | - | - | - | -24256.47% | - | -2845.11% | -1071.53% | -402.52% | -2280.48% | -681.1% | -764.7% | -559.33% |
| Operating Income Growth % | -18.36% | -90.82% | -84.92% | -67.18% | -79.42% | -68.99% | -70.92% | -20.18% | -42.57% | -43.98% | -87.42% | -191.67% | -61.04% | -75.23% | -29.7% | -16.62% | -43.96% | -39.42% | -54.96% | -55.26% |
| EBITDA | -370.19M | -500.63M | -440.69M | -356.92M | -310.93M | -260.91M | -237.04M | -212.92M | -172.84M | -153.85M | -138.1M | -177.13M | -121.1M | -107.02M | -72.62M | -59.11M | -74.1M | -59.76M | -55.66M | -50.85M |
| EBITDA Margin % | -187.38% | - | - | - | - | - | - | - | - | - | - | -23871.29% | - | -2798.74% | -1035.41% | -385.57% | -2207.99% | -655.5% | -734.48% | -537.54% |
| EBITDA Growth % | -19.06% | -91.88% | -85.91% | -67.63% | -79.9% | -69.59% | -71.65% | -20.21% | -42.72% | -43.75% | -90.15% | -199.66% | -63.43% | -79.1% | -30.48% | -16.24% | -44.13% | -39.96% | -55.82% | -57.04% |
| D&A (Non-Cash Add-back) | 2.96M | 4.5M | 4.54M | 4.7M | 4.34M | 3.8M | 3.72M | 3.39M | 2.88M | 2.8M | 2.76M | 2.86M | 2.15M | 1.77M | 2.53M | 2.6M | 2.43M | 2.33M | 2.29M | 2.06M |
| EBIT | -376.01M | -620.59M | -441.62M | -352.96M | -293.78M | -247.79M | -213.42M | -195.32M | -156.29M | -133.23M | -116M | -132.39M | -123.25M | -108.8M | -75.16M | -56.63M | -76.53M | -62.09M | -57.95M | -52.68M |
| Net Interest Income | 3.98M | 11.8M | 7.31M | 9.36M | 10.65M | 22.4M | 24.91M | 21.23M | 20.41M | 21.49M | 23.76M | 18.67M | 10.95M | 10.5M | 7.06M | 5.08M | 2.91M | 867K | 302K | 237K |
| Interest Income | 37.78M | 35.58M | 19.51M | 21.29M | 22.08M | 22.4M | 24.91M | 21.23M | 20.41M | 21.49M | 23.76M | 18.67M | 10.95M | 10.5M | 7.06M | 5.08M | 2.91M | 867K | 302K | 237K |
| Interest Expense | 33.8M | 23.78M | 12.2M | 11.94M | 11.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -36.66M | -139.24M | -8.59M | -3.27M | 10.06M | 16.93M | 27.34M | 20.99M | 19.42M | 23.41M | 24.86M | 18.79M | 10.95M | 10.5M | 7.06M | 5.08M | 2.91M | 867K | 302K | 237K |
| Pretax Income | -409.81M | -644.37M | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -195.32M | -156.29M | -133.23M | -116M | -161.19M | -112.3M | -98.3M | -68.1M | -56.63M | -73.63M | -61.22M | -57.65M | -52.68M |
| Pretax Margin % | -207.44% | - | - | - | - | - | - | - | - | - | - | -21724.26% | - | -2570.55% | -970.89% | -369.41% | -2193.86% | -671.59% | -760.72% | -556.83% |
| Income Tax | -2.35M | 0 | 0 | 0 | 0 | 0 | 0 | -753K | 0 | 0 | 0 | 343K | -3.87M | 0 | 0 | -123K | -297K | 0 | 0 | 0 |
| Effective Tax Rate % | 0.57% | 0% | 0% | 0% | 0% | 0% | 0% | 0.39% | 0% | 0% | 0% | -0.21% | 3.44% | 0% | 0% | 0.22% | 0.4% | 0% | 0% | 0% |
| Net Income | -407.46M | -644.37M | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116M | -161.54M | -108.43M | -98.3M | -68.1M | -56.51M | -73.33M | -61.22M | -57.65M | -52.68M |
| Net Margin % | -206.25% | - | - | - | - | - | - | - | - | - | - | -21770.49% | - | -2570.55% | -970.89% | -368.6% | -2185.01% | -671.59% | -760.72% | -556.83% |
| Net Income Growth % | -33.5% | -160.05% | -112.64% | -87.54% | -95.28% | -85.98% | -83.97% | -20.45% | -44.13% | -35.54% | -70.35% | -185.87% | -47.87% | -60.56% | -18.13% | -7.27% | -38.51% | -38.2% | -55.07% | -54.01% |
| Net Income (Continuing) | -407.46M | -644.37M | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116M | -161.54M | -108.43M | -98.3M | -68.1M | -56.51M | -73.33M | -61.22M | -57.65M | -52.68M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.90 | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 | -0.92 | -0.62 | -0.63 | -0.87 | -0.81 | -0.77 | -0.71 |
| EPS Growth % | -18.01% | -133.59% | -102.65% | -68.14% | -71.28% | -61.73% | -61.43% | 0.88% | 5.05% | 11.96% | -12.9% | -80.95% | -13.79% | -13.58% | 19.48% | 11.27% | -20.83% | -35% | -45.28% | -36.54% |
| EPS (Basic) | -1.90 | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 | -0.92 | -0.62 | -0.63 | -0.87 | -0.81 | -0.77 | -0.71 |
| Diluted Shares Outstanding | 214.95M | 210.89M | 198.1M | 190.13M | 189.23M | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.83M |
| Basic Shares Outstanding | 214.95M | 210.89M | 198.1M | 190.13M | 189.23M | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.82M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |